MONDAY, Nov. 18, 2024 (HealthDay News) — For patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) and then surgery is promising, according to a study published online Nov. 15 in Clinical Cancer Research. Xin Wang, from the Chinese Academy of Medical Sciences and Peking Union Medical College … Continue reading ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer